EE200100025A - Restenoosi ravi - Google Patents
Restenoosi raviInfo
- Publication number
- EE200100025A EE200100025A EEP200100025A EEP200100025A EE200100025A EE 200100025 A EE200100025 A EE 200100025A EE P200100025 A EEP200100025 A EE P200100025A EE P200100025 A EEP200100025 A EE P200100025A EE 200100025 A EE200100025 A EE 200100025A
- Authority
- EE
- Estonia
- Prior art keywords
- treatment
- restenosis
- accetpabel
- bisphosphonate
- pyrophosphate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Mechanical Treatment Of Semiconductor (AREA)
- Saccharide Compounds (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Plant Substances (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL12533698A IL125336A0 (en) | 1998-07-14 | 1998-07-14 | Compositions for inhibition and treatment of restinosis |
PCT/IL1999/000387 WO2000003677A2 (en) | 1998-07-14 | 1999-07-14 | Use of bisphosphonates in the treatment of vascular restenosis |
Publications (1)
Publication Number | Publication Date |
---|---|
EE200100025A true EE200100025A (et) | 2002-06-17 |
Family
ID=11071743
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200100025A EE200100025A (et) | 1998-07-14 | 1999-07-14 | Restenoosi ravi |
Country Status (17)
Country | Link |
---|---|
US (1) | US6719998B1 (et) |
EP (2) | EP1468691B1 (et) |
JP (4) | JP4663116B2 (et) |
KR (1) | KR20010074711A (et) |
CN (1) | CN1321090A (et) |
AT (2) | ATE262338T1 (et) |
AU (1) | AU758882B2 (et) |
BR (1) | BR9912066A (et) |
CA (1) | CA2337175C (et) |
DE (2) | DE69942510D1 (et) |
EE (1) | EE200100025A (et) |
ES (2) | ES2347553T3 (et) |
IL (3) | IL125336A0 (et) |
NO (1) | NO20010224L (et) |
PL (1) | PL345782A1 (et) |
SK (1) | SK472001A3 (et) |
WO (1) | WO2000003677A2 (et) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7008645B2 (en) * | 1998-07-14 | 2006-03-07 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Method of inhibiting restenosis using bisphosphonates |
IL125336A0 (en) * | 1998-07-14 | 1999-03-12 | Yissum Res Dev Co | Compositions for inhibition and treatment of restinosis |
JP2003500352A (ja) * | 1999-05-21 | 2003-01-07 | ノバルティス アクチエンゲゼルシャフト | 血管形成を処置するためのビスホスホン酸の使用 |
EP1267888A4 (en) * | 2000-01-04 | 2005-12-28 | Univ California | USE OF LOW-DOSEED BISPHOSPHONATES FOR PREVENTING THE CALIBRATION OF HEART AND ARTERIES |
ATE368482T1 (de) * | 2001-02-16 | 2007-08-15 | Abbott Lab Vascular Entpr Ltd | Implantate mit fk506 zur restenosebehandlung und -prophylaxe |
US6656506B1 (en) * | 2001-05-09 | 2003-12-02 | Advanced Cardiovascular Systems, Inc. | Microparticle coated medical device |
US20060166937A1 (en) * | 2002-10-15 | 2006-07-27 | Prescott Margaret F | Bisphosphonates for the treatment of atherosclerosis and device comprising them |
US8034361B2 (en) * | 2002-11-12 | 2011-10-11 | Advanced Cardiovascular Systems, Inc. | Stent coatings incorporating nanoparticles |
US10517883B2 (en) | 2003-06-27 | 2019-12-31 | Zuli Holdings Ltd. | Method of treating acute myocardial infarction |
US20060051407A1 (en) * | 2003-06-27 | 2006-03-09 | Yoram Richter | Method of treating ischemia-reperfusion injury |
AU2004253527B2 (en) * | 2003-06-27 | 2010-04-08 | Zuli Holdings Ltd. | Method of treating acute coronary syndromes |
US20050153937A1 (en) * | 2003-11-07 | 2005-07-14 | Gershon Golomb | Desensitization of compliment activation using monocyte/macrophage inhibitory compounds |
CN100364544C (zh) * | 2004-07-21 | 2008-01-30 | 上海第二医科大学附属瑞金医院 | 一种携带二氯亚甲基二膦酸的明胶微粒及制备方法 |
US7687482B2 (en) | 2006-03-17 | 2010-03-30 | The Board Of Trustees Of The University Of Illinois | Bisphosphonate compounds and methods |
WO2008128056A1 (en) | 2004-10-08 | 2008-10-23 | The Board Of Trustees Of The University Of Illinois | Bisphosphonate compounds and methods with enhanced potency for multiple targets including fpps, ggpps, and dpps |
EP1802641B8 (en) | 2004-10-08 | 2012-03-07 | The Board Of Trustees Of The University Of Illinois | Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases |
EP2316441A1 (en) | 2005-02-17 | 2011-05-04 | Hadasit Medical Research Services And Development | Bisphosphonates for treating endometriosis |
CN101198316A (zh) * | 2005-03-17 | 2008-06-11 | 伊兰制药国际有限公司 | 纳米微粒双膦酸盐组合物 |
US20080181928A1 (en) * | 2006-12-22 | 2008-07-31 | Miv Therapeutics, Inc. | Coatings for implantable medical devices for liposome delivery |
US8802184B2 (en) | 2007-05-30 | 2014-08-12 | Abbott Cardiovascular Systems Inc. | Medical devices containing biobeneficial particles |
EP2211926A2 (en) * | 2007-10-10 | 2010-08-04 | Miv Therapeutics Inc. | Lipid coatings for implantable medical devices |
US20090148491A1 (en) * | 2007-12-05 | 2009-06-11 | Abbott Cardiovascular Systems Inc. | Dual-Targeted Drug Carriers |
EP2255199A1 (en) * | 2008-02-19 | 2010-12-01 | Jovesis Inc. | Microparticle compositions to modify cancer promoting cells |
BRPI0915885A2 (pt) * | 2008-07-09 | 2015-11-03 | Univ Nebraska | micelas funcionais para a liberação direcionada de substâncias químicas em tecido duro |
US20130315981A1 (en) * | 2010-06-25 | 2013-11-28 | The Trustees Of Columbia University In The City Of New York | Method for inducing fat loss in mammals |
GB201200868D0 (en) * | 2012-01-19 | 2012-02-29 | Depuy Int Ltd | Bone filler composition |
US9993427B2 (en) | 2013-03-14 | 2018-06-12 | Biorest Ltd. | Liposome formulation and manufacture |
EP3142670B1 (en) | 2014-05-16 | 2018-08-22 | Biorest Ltd. | Use of bisphosphonates as hiv/aids adjunctive treatment |
US11904082B2 (en) | 2016-08-01 | 2024-02-20 | Kaneka Corporation | Adsorbent for calciprotein particles, adsorption removal system, and method for utilization thereof |
CN106361701B (zh) * | 2016-08-31 | 2019-08-27 | 上海交通大学 | 一种脂质体药物载体及其制备方法和应用 |
FR3068233A1 (fr) * | 2017-07-03 | 2019-01-04 | Omnium De Revalorisation Industrielle Odri | Dispositif medical intra-arteriel et applications |
JP6613290B2 (ja) | 2017-11-28 | 2019-11-27 | 株式会社Subaru | 運転アドバイス装置及び運転アドバイス方法 |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4067971A (en) | 1976-05-13 | 1978-01-10 | The Procter & Gamble Company | Therapeutic composition |
US4216211A (en) | 1977-10-31 | 1980-08-05 | The Procter & Gamble Company | Therapeutic composition |
WO1988000289A1 (en) | 1986-07-09 | 1988-01-14 | Engine Technology Limited | Piston rings |
CH675422A5 (et) * | 1988-03-31 | 1990-09-28 | Symphar Sa | |
IL91362A0 (en) | 1989-08-20 | 1990-03-19 | Yissum Res Dev Co | Bisphosphonates,process for preparing them and pharmaceutical compositions containing them |
US5196409A (en) | 1989-08-20 | 1993-03-23 | Yissum, Research Development Company Of The Hebrew University Of Jerusalem | Bisphosphonates, pharmaceutical compositions, and process for the treatment of irregularities in calcium metabolism |
PH27186A (en) | 1989-09-07 | 1993-04-16 | Ciba Geigy Ag | Double-coated granules of disodium pamidronate |
CA2042159A1 (en) | 1990-05-31 | 1991-12-01 | Miguel A. Ondetti | Method for preventing onset of restenosis after angioplasty employing an ace inhibitor |
AU678760B2 (en) * | 1991-11-11 | 1997-06-12 | Trustees Of The University Of Pennsylvania, The | Methods of inhibiting restenosis |
US5358941A (en) | 1992-12-02 | 1994-10-25 | Merck & Co., Inc. | Dry mix formulation for bisphosphonic acids with lactose |
FI92465C (fi) | 1993-04-14 | 1994-11-25 | Risto Tapani Lehtinen | Menetelmä endo-osteaalisten materiaalien käsittelemiseksi |
US5994341A (en) | 1993-07-19 | 1999-11-30 | Angiogenesis Technologies, Inc. | Anti-angiogenic Compositions and methods for the treatment of arthritis |
US5457113A (en) * | 1993-10-15 | 1995-10-10 | Eli Lilly And Company | Methods for inhibiting vascular smooth muscle cell proliferation and restinosis |
DE69630514D1 (de) * | 1995-01-05 | 2003-12-04 | Univ Michigan | Oberflächen-modifizierte nanopartikel und verfahren für ihre herstellung und verwendung |
US5652227A (en) | 1995-01-30 | 1997-07-29 | Teronen; Olli Pekka | Inhibition of the degradation of connective tissue matrix protein components in mammals |
US5741514A (en) * | 1995-08-31 | 1998-04-21 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Method for reducing serum lipoprotein(a) concentration |
PT932399E (pt) * | 1996-03-12 | 2006-05-31 | Pg Txl Co Lp | Pro-farmacos de paclitaxel hidrossoluveis |
AU2783397A (en) * | 1996-05-15 | 1997-12-05 | University Of Sheffield, The | Isopentenyl pyrophosphate isomerase (ipi) and/or prenyl transferase inhibitors |
KR100192215B1 (ko) | 1996-09-03 | 1999-06-15 | 강재헌 | 3-아미노-1-히드록시프로판-1,1-디포스폰산의 제조방법 |
AU729869B2 (en) * | 1997-01-17 | 2001-02-15 | Merck & Co., Inc. | Integrin antagonists |
US5760030A (en) | 1997-06-30 | 1998-06-02 | Eli Lilly And Company | Benzothiophene compounds and methods of use |
US5932580A (en) | 1997-12-01 | 1999-08-03 | Yissum Research And Development Company Of The Hebrew University Of Jerusalem | PDGF receptor kinase inhibitory compounds their preparation and compositions |
AU760703B2 (en) * | 1998-01-29 | 2003-05-22 | Merck & Co., Inc. | Methods of identifying modulators of kinases responsive to stress |
IL125336A0 (en) * | 1998-07-14 | 1999-03-12 | Yissum Res Dev Co | Compositions for inhibition and treatment of restinosis |
EP0998932A1 (de) | 1998-10-09 | 2000-05-10 | Boehringer Mannheim Gmbh | Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung |
US5932563A (en) | 1998-10-23 | 1999-08-03 | Ohio State Research Foundation | Methods for treating spinal cord injury |
DE69907258T2 (de) | 1998-12-10 | 2003-11-06 | Aesgen Inc | Verfahren zur herstellung von dinatriumpamidronat |
WO2000064516A1 (en) | 1999-04-22 | 2000-11-02 | Hydromed Sciences A Division Of Gp Strategies Corporation | Controlled delivery of bisphosphonates |
-
1998
- 1998-07-14 IL IL12533698A patent/IL125336A0/xx unknown
-
1999
- 1999-07-14 SK SK47-2001A patent/SK472001A3/sk unknown
- 1999-07-14 PL PL99345782A patent/PL345782A1/xx unknown
- 1999-07-14 AU AU46462/99A patent/AU758882B2/en not_active Expired
- 1999-07-14 DE DE69942510T patent/DE69942510D1/de not_active Expired - Lifetime
- 1999-07-14 AT AT99929687T patent/ATE262338T1/de not_active IP Right Cessation
- 1999-07-14 DE DE69915834T patent/DE69915834T2/de not_active Expired - Lifetime
- 1999-07-14 EE EEP200100025A patent/EE200100025A/et unknown
- 1999-07-14 ES ES04006854T patent/ES2347553T3/es not_active Expired - Lifetime
- 1999-07-14 EP EP04006854A patent/EP1468691B1/en not_active Expired - Lifetime
- 1999-07-14 AT AT04006854T patent/ATE471149T1/de not_active IP Right Cessation
- 1999-07-14 CN CN99810638A patent/CN1321090A/zh active Pending
- 1999-07-14 KR KR1020017000569A patent/KR20010074711A/ko not_active Application Discontinuation
- 1999-07-14 US US09/743,705 patent/US6719998B1/en not_active Expired - Lifetime
- 1999-07-14 WO PCT/IL1999/000387 patent/WO2000003677A2/en not_active Application Discontinuation
- 1999-07-14 ES ES99929687T patent/ES2219028T3/es not_active Expired - Lifetime
- 1999-07-14 BR BR9912066-6A patent/BR9912066A/pt not_active IP Right Cessation
- 1999-07-14 IL IL14217299A patent/IL142172A0/xx active IP Right Grant
- 1999-07-14 CA CA002337175A patent/CA2337175C/en not_active Expired - Lifetime
- 1999-07-14 EP EP99929687A patent/EP1094820B1/en not_active Expired - Lifetime
- 1999-07-14 JP JP2000559812A patent/JP4663116B2/ja not_active Expired - Lifetime
-
2001
- 2001-01-12 NO NO20010224A patent/NO20010224L/no unknown
- 2001-03-21 IL IL142172A patent/IL142172A/en not_active IP Right Cessation
-
2010
- 2010-10-01 JP JP2010223610A patent/JP5498342B2/ja not_active Expired - Lifetime
-
2013
- 2013-08-22 JP JP2013172443A patent/JP5903081B2/ja not_active Expired - Lifetime
-
2015
- 2015-10-19 JP JP2015205518A patent/JP6088619B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE200100025A (et) | Restenoosi ravi | |
DE69840645D1 (en) | Benzamidinderivate | |
RS50071B (sr) | Novi oblik soli pantoprazola | |
AU1044500A (en) | Imidazonaphthyridines | |
CU23088A3 (es) | Compuestos de tetra-hidropiridina. | |
ATE297904T1 (de) | Halo-alkoxycarbonylverbindungen | |
ITRM920734A0 (it) | Composizioni per la stabilizzazione dei polimeri. (caso 153-5550) | |
DK0605381T3 (da) | Polymerforbindelse, især til medicinske anvendelser | |
FR2668697B1 (fr) | Dissecteur, notamment pour chirurgie endoscopique. | |
ID20165A (id) | Penggunaan asam 2-(3,4-dimetoksisinamoil)aminobenzoat untuk pembuatan obat untuk pengobatan atau pencegahan restenosis | |
ES2097181T3 (es) | Composicion antidepresiva a base de nicotinamida-adenina-dinucleotido. | |
ITTO930042A1 (it) | Macchina germicida automatica per la sterilizzazione di qualsivoglia tipo di cornetta telefonica. | |
ITTO910075A1 (it) | Attrezzo chirurgico per organi urologici. |